Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease.
- 2015-07-02
- Digestive diseases and sciences 60(11)
- Martina Klemenak
- Jernej Dolinšek
- Tomaž Langerholc
- Diana Di Gioia
- Dušanka Mičetić-Turk
- PubMed: 26134988
- DOI: 10.1007/s10620-015-3769-7
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Sample size
- n = 49
- Population
- 49 children with celiac disease on gluten-free diet
- Methods
- Double-blinded, placebo-controlled trial, 3 months of B. breve BR03 and B632 (2×10^9 CFU/day)
- Blinding
- Double-blind
- Duration
- 3 months
- Funding
- Unclear
- Rigorous Journal